The management of hot flushes for men treated with androgen deprivation therapy for prostate cancer: a survey of UK practice

Abstract

Get full access to this article

View all access options for this article.

References

Walker

Tran

Robinson

JW.

Luteinizing hormone-releasing hormone agonists: a quick reference for prevalence rates of potential adverse effects. Clin Genitourin Cancer 2013; 11(4): 375–384.

Downing

Wright

Hounsome

, et al. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol 2019; 20(3): 436–447.

Morrow

Mattair

Hortobagyi

GN.

Hot flashes: a review of pathophysiology and treatment modalities. Oncologist 2011; 16(11): 1658–1664.

National Institute for Health and Care Excellence. Prostate cancer: diagnosis & management, https://www.nice.org.uk/guidance/ng131/chapter/Recommendations (2019, accessed 13 February 2020).

European Association of Urology. Prostate cancer guidelines, http://uroweb.org/guideline/prostate-cancer/ (2019, accessed 13 February 2020).